Vertex Pharmaceuticals (MA) (VRTX) Announces Exercise of Option by Underwriters of its Public Offering of Common Stock  
12/4/2009 9:38:16 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the underwriters of its public offering have exercised in full their option to purchase an additional 1,500,000 shares of common stock at the public offering price of $38.50 per share. The exercise of the option brings the total shares of common stock sold by Vertex in the offering to 13,000,000 shares. Vertex expects to receive total gross proceeds from the offering, before commissions and expenses, of $500.5 million.